Polypeptides
Abstract
NATURAL APPEARING G-CSF DERIVATIVES ARE DESCRIBED AND HAVE AT LEAST ONE OF THE BIOLOGICAL PROPERTIES OF THE G-CSF OF NATURAL APPEARANCE, AND A MINIMUM SOLUTION STABILITY OF 35% IN 5 MG / ML, IN WHICH THE DERIVATIVE HAS AT LEAST CYS ELEVATED 17 OF THE ORIGINAL SEQUENCE REPLACED BY A WASTE TO BE ELEVATED 17 AND ASP ELEVATED 27 OF THE ORIGINAL SEQUENCE REPLACED BY A WASTE TO BE ELEVATED 27. NUCLEOTIDE SEQUENCES CODING PART OR ALL OF THE AMINO ACID SEQUENCE OF THE DERIVATIVES OF THE INVENTION MAY BE INCORPORATED IN VASIC PLASMIDS OR VIRALS THAT REPRODUCE SELF-EMPLOYED APPLICATORS TO TRANSFORM OR TRANSFER CUEULAR RECEIVING CELLS IN CULTIVATION.

Term
Term ended
Projected expiry passed 29 April 2011, 15.4 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
13 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5 Sheet 6 Sheet 7 Sheet 8 Sheet 9 Sheet 10 Sheet 11 Sheet 12 Sheet 13
39 members in 26 offices
Priority claims20
| Document | Office | Kind | Date |
|---|---|---|---|
| 19900009623 | United Kingdom | – | |
| 9009623 | United Kingdom | A | |
| 9009623 | United Kingdom | A | |
| 19900013773 | United Kingdom | – | |
| 9013773 | United Kingdom | A | |
| 9013773 | United Kingdom | A | |
| 19900016215 | United Kingdom | – | |
| 9016215 | United Kingdom | A | |
| 9016215 | United Kingdom | A | |
| 19910002799 | United Kingdom | – | |
| 9102799 | United Kingdom | A | |
| 9102799 | United Kingdom | A | |
| 9013773 | – | – | – |
| 9016215 | – | – | – |
| 9102799 | – | – | – |
| 91303868 | – | – | – |
| GB19900009623 | – | – | – |
| GB19900013773 | – | – | – |
| GB19900016215 | – | – | – |
| GB19910002799 | – | – | – |
Members39
| Document | Office | Kind | |
|---|---|---|---|
| GB9009623D0 | United Kingdom | D0 | |
| GB9013773D0 | United Kingdom | D0 | |
| GB9016215D0 | United Kingdom | D0 | |
| GB9102799D0 | United Kingdom | D0 | |
| NO911696D0 | Norway | D0 | |
| GB9107846D0 | United Kingdom | D0 | |
| CA2041454A1 | Canada | A1 | |
| FI912086A | Finland | A | |
| FI912086A7 | Finland | A7 | |
| FI912086L | Finland | L | |
| NO911696L | Norway | L | |
| IE911440A1 | Ireland | A1 | |
| AU7628491A | Australia | A | |
| HU911440D0 | Hungary | D0 | |
| KR910018406A | Republic of Korea | A | |
| EP0459630A2 | European Patent Office (EPO) | A2 | |
| ZW4891A1 | Zimbabwe | A1 | |
| MW891A1 | Malawi | A1 | |
| ZA913234B | South Africa | B | |
| PT97529A | Portugal | A | |
| CS125091A3 | Czechoslovakia (until 1993) | A3 | |
| IL97993D0 | Israel | D0 | |
| ZM1991A1 | Zambia | A1 | |
| EP0459630A3 | European Patent Office (EPO) | A3 | |
| HUT60769A | Hungary | A | |
| NZ237974A | New Zealand | A | |
| AU644647B2 | Australia | B2 | |
| BG94328A | Bulgaria | A | |
| JPH06100593A | Japan | A | |
| TW226022B | Taiwan Province of China | B | |
| US5416195A | United States of America | A | |
| EP0459630B1 | European Patent Office (EPO) | B1 | |
| AT169336T | Austria | T | |
| ATE169336T1 | Austria | T1 | |
| DE69129927D1 | Germany | D1 | |
| ES2118737T3This record | Spain | T3 | |
| GR3027590T3 | Greece | T3 | |
| DE69129927T2 | Germany | T2 | |
| DK0459630T3 | Denmark | T3 |
2 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Definitive protectionFG2A | FG2A | |
| Grant refusedFC2A | FC2A |
Numbers
- Publication
- 2118737
- Publication, DOCDB
- 2118737
- Publication, EPODOC
- ES2118737T
- Application
- 91303868
- Application, DOCDB
- 91303868
- Application, EPODOC
- ES19910303868T
Titles2
- Spanish
- POLIPEPTIDOS
- English
- POLYPEPTIDES.
Classification
- CPC, 8
- C12N15/70
- C07K14/00
- A61K38/00
- C07K14/535
- C12N15/68
- Y10S930/145
- A61P43/00
- A61P7/00
- IPC, 17
- A61K38 00
- A61P7 00
- A61P43 00
- C07K14 00
- C07K14 52
- C07K14 53
- C07K14 535
- C12N1 19
- C12N1 21
- C12N15 09
- C12N15 27
- C12N15 68
- C12N15 70
- C12P21 02
- C12R1 19
- C12R1 865
- C12R1 91